trending Market Intelligence /marketintelligence/en/news-insights/trending/mthrIQhtp1m9Kwa5rJwt2g2 content esgSubNav
In This List

Grifols sells 2 businesses to shareholder Scranton Enterprises for $537M

Blog

Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


Grifols sells 2 businesses to shareholder Scranton Enterprises for $537M

Spanish biotechnology company Grifols SA said it sold two businesses it acquired earlier this year to its existing shareholder Scranton Enterprises BV.

Scranton will pay $537 million for the businesses, effectively the same price Grifols paid when it acquired Haema AG for €220 million in June and Biotest US Corp. for $286 million in August.

Biotest and Haema will continue to provide plasma to Grifols under a supply agreement that has been extended to a 30-year period. Grifols also has the ability to repurchase the businesses.